Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
36.35
+0.07 (0.19%)
At close: Aug 15, 2025, 4:00 PM
36.11
-0.24 (-0.66%)
After-hours: Aug 15, 2025, 7:54 PM EDT

Royalty Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
1,021858.981,13542.83619.73975.04
Upgrade
Depreciation & Amortization
1.38--5.672323.06
Upgrade
Other Amortization
21.2419.5620.521.3620.1611.72
Upgrade
Asset Writedown & Restructuring Costs
---615.83-65.05
Upgrade
Loss (Gain) From Sale of Investments
-10.5-194.46-317.9840.2630.21-265.67
Upgrade
Loss (Gain) on Equity Investments
-37.8-16.22-10.0648.1253.87-2.13
Upgrade
Stock-Based Compensation
92.342.342.362.172.445.43
Upgrade
Provision & Write-off of Bad Debts
-394.65732.46560.66904.24452.84230.84
Upgrade
Other Operating Activities
-1,430-1,670-1,609-2,076-1,484-1,207
Upgrade
Change in Accounts Receivable
3,1252,9833,2012,5072,2962,122
Upgrade
Change in Accounts Payable
5.03-2.296.242.29-4.59-0.77
Upgrade
Change in Other Net Operating Assets
12.9955.67-0.8530.388.476.36
Upgrade
Operating Cash Flow
2,4062,7692,9882,1442,0182,035
Upgrade
Operating Cash Flow Growth
-9.85%-7.32%39.36%6.27%-0.84%22.04%
Upgrade
Sale (Purchase) of Intangibles
-1,693-2,506-2,116-1,742-2,192-2,182
Upgrade
Investment in Securities
545.54-99.4557.17712.22339.82-577.07
Upgrade
Other Investing Activities
-284.55-72.96-14.44--18.6-
Upgrade
Investing Cash Flow
-1,506-2,678-2,073-1,029-1,870-2,759
Upgrade
Short-Term Debt Issued
--350---
Upgrade
Long-Term Debt Issued
-1,471--1,27311,891
Upgrade
Total Debt Issued
-1,471350-1,27311,891
Upgrade
Short-Term Debt Repaid
---350---
Upgrade
Long-Term Debt Repaid
---1,000---11,210
Upgrade
Total Debt Repaid
---1,350---11,210
Upgrade
Net Debt Issued (Repaid)
-1,471-1,000-1,273680.63
Upgrade
Issuance of Common Stock
-----1,150
Upgrade
Repurchase of Common Stock
-1,150-229.65-304.76---
Upgrade
Common Dividends Paid
-376.32-376.47-358.33-333.32-285.18-397.84
Upgrade
Other Financing Activities
-506.26-503.97-485.67-611.53-602.2453.99
Upgrade
Financing Cash Flow
-2,033361.15-2,149-944.86385.111,487
Upgrade
Net Cash Flow
-1,133452.02-1,234169.7532.37762.48
Upgrade
Cash Interest Paid
219.42159.57169.17170.14130.43103.2
Upgrade
Levered Free Cash Flow
-746.67-1,759-1,245-1,384-1,547-1,087
Upgrade
Unlevered Free Cash Flow
-601.53-1,637-1,149-1,288-1,463-993.85
Upgrade
Change in Working Capital
3,1433,0373,2072,5402,3002,198
Upgrade
Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q